ShockWave Medical (SWAV) Rises 5.66% on June 21

Equities Staff  |

Today ShockWave Medical Inc (NASDAQ: SWAV) is trading 5.66% higher.

The latest price, as of 12:09:41 est, was $166.94. ShockWave Medical has risen $8.96 over the previous day’s close.

187,578 shares exchanged hands.

As of the previous close, ShockWave Medical has moved YTD 11.30%. The company expects its next earnings on 2022-08-08.

For technical charts, analysis, and more on ShockWave Medical visit the company profile.

About ShockWave Medical Inc

Shockwave Medical is focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. Shockwave Medical aims to establish a new standard of care for the interventional treatment of atherosclerotic cardiovascular disease through differentiated and proprietary local delivery of sonic pressure waves for the treatment of calcified plaque, which Shockwave Medical refers to as Intravascular Lithotripsy (IVL). IVL is a minimally invasive, easy-to-use and safe way to significantly improve patient outcomes.

To get more information on ShockWave Medical Inc and to follow the company's latest updates, you can visit the company's profile page here: ShockWave Medical Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

The Best Laid Plans of Mice and Men — Part II
Why I’m Buying the 'New' Value Stocks
Investors Must Understand 5G Wireless Growth Wave: Jeff Kagan
'Goldilocks' Stocks Will Define This Decade



Market Movers

Sponsored Financial Content